The patients who developed HCC showed significantly older age (median 50 vs. 49 years), higher prevalence of cirrhosis (90.7% vs. 45.9%), higher liver stiffness values (median 13.9 vs. 7.2 kPa), lower platelet counts (median 122.0 vs. 172.5 × 103/μL), lower alanine aminotransferase (ALT) levels (median 47.5 vs. 48.0 IU/L), lower serum albumin levels (median 4.0 vs. 4.2 g/dL), and prolonged prothrombin time (median international normalized ratio: 1.04 vs. 1.00; all p < 0.05) than did those who did not (Table S1). The gene discussed is F2; the disease is Cirrhosis.